NIT
TTPH

NumerixS Investment Technologies’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

NumerixS Investment Technologies’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,122
Closed -$289K – 1289
2016
Q1 		$289K Buy
3,122
+1,845
+144% +$184K 0.03% 659
2015
Q4 		$256K Sell
1,277
-5,416
-81% -$1.08M 0.03% 635
2015
Q3 		$999K Buy
+6,693
New +$4.91M 0.11% 225

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

NumerixS Investment Technologies's TTPH Position: Q2 2016 in Review

NumerixS Investment Technologies sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 3,122 shares — an estimated $289K sold.

NumerixS Investment Technologies first reported a position in TTPH in Q3 2015 and held it in 3 quarters. The position peaked at $999K in Q3 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • NumerixS Investment Technologies reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,122 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $289K.
  • NumerixS Investment Technologies first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • NumerixS Investment Technologies's Tetraphase Pharmaceuticals, Inc. position peaked at $999K in Q3 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on NumerixS Investment Technologies's 13F filing for Q2 2016, filed 11 Aug 2016.